Loading...

Helena R Chang

Title(s)Professor, Surgery
SchoolMedicine
Phone52144
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Ethnicity-based proteomic biomarkers in breast cancer
    NIH/NCI R01CA093736Sep 27, 2002 - Aug 31, 2006
    Role: Principal Investigator
    GENERATION OF MABS AGAINST PANCREATIC CANCER
    NIH/NCI R29CA056299Jul 1, 1992 - Sep 30, 1997
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Chang HR, Glaspy J, Allison MA, Kass FC, Elashoff R, Chung DU, Gornbein J. Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment. Cancer. 2010 Sep 15; 116(18):4227-37. PMID: 20549829.
      View in: PubMed
    2. Chang HR. Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer. Cancer. 2010 Jun 15; 116(12):2856-67. PMID: 20564392.
      View in: PubMed
    Helena's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Similar People
    People who share similar concepts with this person.
    _
    Same Department